JP Morgan Chase
ALGS icon

JP Morgan Chase’s Aligos Therapeutics ALGS Stock Holding History

JP Morgan Chase’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Sell
344
-330
-49% -$2.04K ﹤0.01% 7238
2026
Q1 		$4.42K Buy
674
+368
+120% +$2.79K ﹤0.01% 6904
2025
Q4 		$2.85K Sell
306
-402
-57% -$3.79K ﹤0.01% 6887
2025
Q3 		$6.94K Buy
708
+682
+2,623% +$6.23K ﹤0.01% 6718
2025
Q2 		$187 Hold
26
– – ﹤0.01% 6787
2025
Q1 		$215 Hold
26
– – ﹤0.01% 6790
2024
Q4 		$1.04K Hold
26
– – ﹤0.01% 6725
2024
Q3 		$225 Sell
26
-1
-4% -$12 ﹤0.01% 6894
2024
Q2 		$237 Hold
27
– – ﹤0.01% 6768
2024
Q1 		$663 Hold
27
– – ﹤0.01% 6684
2023
Q4 		$450 Hold
27
– – ﹤0.01% 6940
2023
Q3 		$506 Hold
27
– – ﹤0.01% 6725
2023
Q2 		$657 Hold
27
– – ﹤0.01% 6511
2023
Q1 		$1K Hold
27
– – ﹤0.01% 6486
2022
Q4 		$1K Sell
27
-125
-82% -$3.15K ﹤0.01% 6372
2022
Q3 		$5K Buy
152
+89
+141% +$2.96K ﹤0.01% 6082
2022
Q2 		$2K Sell
63
-524
-89% -$17.8K ﹤0.01% 6270
2022
Q1 		$31K Buy
587
+12
+2% +$961 ﹤0.01% 5946
2021
Q4 		$170K Sell
575
-52
-8% -$19K ﹤0.01% 5438
2021
Q3 		$244K Sell
627
-409
-39% -$162K ﹤0.01% 5129
2021
Q2 		$529K Sell
1,036
-145
-12% -$92.4K ﹤0.01% 4660
2021
Q1 		$672K Sell
1,181
-406
-26% -$270K ﹤0.01% 4491
2020
Q4 		$1.1M Buy
+1,587
New +$773K ﹤0.01% 3900

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's ALGS Position: Q2 2026 in Review

JP Morgan Chase reduced its Aligos Therapeutics (ALGS) stake by 49% in Q2 2026, selling an estimated $2.04K and leaving 344 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #7238.

JP Morgan Chase first reported a position in ALGS in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.1M in Q4 2020. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

  • JP Morgan Chase held 344 shares of Aligos Therapeutics worth $1.87K as of Q2 2026.
  • JP Morgan Chase sold 330 Aligos Therapeutics shares in Q2 2026, an estimated $2.04K.
  • Aligos Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7238 holding.
  • JP Morgan Chase first reported a position in Aligos Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's Aligos Therapeutics position peaked at $1.1M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.